Contents Issue 47 • January 2022 In association with When is a drug a device? We explore the regulatory grey area between drugs and devices and what it can mean for manufacturers IN DEPTH Tackling telemedicine fraudsters Comment Omicron could energise flu testing Briefing Industry news Medical industry briefing Covid-19 briefing Comment Omicron variant could energise flu testing MicroLabs aims to boost Covid-19 surveillance IoT will tackle demand on mental health services In Depth When is a drug a device? 3D printing in drug manufacturing Tackling telemedicine fraudsters ESG in clinical trials: key themes Winners of our Excellence Awards In Data Investment themes to watch Data analytics hiring on the rise North America’s big data hiring boom Markets and indices Macro-economic data 01/07/2022 10:22:19
Comment
Omicron could energise flu testing